These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15041785)

  • 21. Abnormal renal, hepatic, and muscle glucose metabolism following glucose ingestion in type 2 diabetes.
    Meyer C; Woerle HJ; Dostou JM; Welle SL; Gerich JE
    Am J Physiol Endocrinol Metab; 2004 Dec; 287(6):E1049-56. PubMed ID: 15304374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oleanolic acid improves hepatic insulin resistance via antioxidant, hypolipidemic and anti-inflammatory effects.
    Wang X; Liu R; Zhang W; Zhang X; Liao N; Wang Z; Li W; Qin X; Hai C
    Mol Cell Endocrinol; 2013 Aug; 376(1-2):70-80. PubMed ID: 23791844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NAFLD and diabetes mellitus.
    Tilg H; Moschen AR; Roden M
    Nat Rev Gastroenterol Hepatol; 2017 Jan; 14(1):32-42. PubMed ID: 27729660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hepatic glucose metabolism and pathogenesiis of diabetes mellitus].
    Ogawa W
    Nihon Rinsho; 2012 May; 70 Suppl 3():90-4. PubMed ID: 22768501
    [No Abstract]   [Full Text] [Related]  

  • 25. Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues.
    Firth RG; Bell PM; Marsh HM; Hansen I; Rizza RA
    J Clin Invest; 1986 May; 77(5):1525-32. PubMed ID: 3517067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
    Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
    Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of hepatic glucose production in healthy subjects and patients with non-insulin-dependent diabetes mellitus.
    Tappy L
    Diabete Metab; 1995 Oct; 21(4):233-40. PubMed ID: 8529757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of free fatty acids (FFA) in the regulation of intrahepatic fluxes of glucose and glycogen metabolism during short-term starvation in healthy volunteers.
    Sprangers F; Romijn JA; Endert E; Ackermans MT; Sauerwein HP
    Clin Nutr; 2001 Apr; 20(2):177-9. PubMed ID: 11327747
    [No Abstract]   [Full Text] [Related]  

  • 30. Genetic Disruption of Protein Kinase STK25 Ameliorates Metabolic Defects in a Diet-Induced Type 2 Diabetes Model.
    Amrutkar M; Cansby E; Chursa U; Nuñez-Durán E; Chanclón B; Ståhlman M; Fridén V; Mannerås-Holm L; Wickman A; Smith U; Bäckhed F; Borén J; Howell BW; Mahlapuu M
    Diabetes; 2015 Aug; 64(8):2791-804. PubMed ID: 25845663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The constitutive activation of Egr-1/C/EBPa mediates the development of type 2 diabetes mellitus by enhancing hepatic gluconeogenesis.
    Shen N; Jiang S; Lu JM; Yu X; Lai SS; Zhang JZ; Zhang JL; Tao WW; Wang XX; Xu N; Xue B; Li CJ
    Am J Pathol; 2015 Feb; 185(2):513-23. PubMed ID: 25438063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Impaired hepatic glucose metabolism].
    Tamura Y; Sato F
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():131-5. PubMed ID: 15779356
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo metabolic defects in non-insulin-dependent diabetes mellitus.
    Bonadonna RC
    Horm Res; 1993; 39 Suppl 3():102-6. PubMed ID: 8262485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolism: a higher power for insulin.
    Gribble FM
    Nature; 2005 Apr; 434(7036):965-6. PubMed ID: 15846327
    [No Abstract]   [Full Text] [Related]  

  • 36. Kidney: its impact on glucose homeostasis and hormonal regulation.
    Mitrakou A
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S66-72. PubMed ID: 21864754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular pathophysiology of hepatic glucose production.
    Sharabi K; Tavares CD; Rines AK; Puigserver P
    Mol Aspects Med; 2015 Dec; 46():21-33. PubMed ID: 26549348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interdependence of hepatic lipid and glucose metabolism: novel pharmacological targets for diabetes.
    Lind P
    Curr Opin Investig Drugs; 2004 Apr; 5(4):395-401. PubMed ID: 15134280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is postprandial hypertriglyceridaemia in relatives of type 2 diabetic subjects a consequence of insulin resistance?
    Kriketos A; Milner KL; Denyer G; Campbell L
    Eur J Clin Invest; 2005 Feb; 35(2):117-25. PubMed ID: 15667583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes.
    Lewis GF; Carpentier A; Adeli K; Giacca A
    Endocr Rev; 2002 Apr; 23(2):201-29. PubMed ID: 11943743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.